Association of interleukin-6 -174 G>C promoter polymorphism with increased risk of type 2 diabetes mellitus patients with diabetic nephropathy in Turkey

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 1, 2014, Pages 62-65

  Karadeniz, Muammer ^a   Erdogan, Mehmet ^b   Berdeli, Afig ^c   Yilmaz, Candeger ^b  

^a SIFA UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; RISK FACTOR; TURKEY (REPUBLIC); VENOUS BLOOD;

AGED; BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA PRIMERS; HUMANS; INTERLEUKIN-6; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TURKEY;

EID: 84891863355     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0357     Document Type: Article

References (28)

1. Abbott F, Ryan JJ, Ceska M, et al. (1991) Interleukin-1b stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int 40:597-605.
2. Coleman DL, Ruef C (1992) Interleukin-6: an autocrine regulator of mesangial cell growth. Kidney Int 41:604-606.
3. Das SK, Hasstedt SJ, Zhang Z, Elbein SC (2004) Linkage and association mapping of a chromosome 1q21-q24 type 2 diabetes susceptibility locus in Northern European Caucasians. Diabetes 53:492-499.
4. Elbein SC, Hoffman MD, Teng K, et al. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175-1182.
5. Elbein SC, Zheng W, Wang X, et al. (2004) Novel T2DM locus on chromosome 4 and confirmation of chromosome 1q21 T2DM linkage in multiplex African American families. Diabetes 53(Suppl 2):A270.
6. Fernandez-Real JM, Broch M, Vendrell J, et al. (2000a) Interleukin- 6 gene polymorphism and insulin sensitivity. Diabetes 49:517-520.
7. Fernandez-Real JM, Broch M, Vendrell J, et al. (2000b) Interleukin- 6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85:1334-1339.
8. Fishman D, Faulds G, Jeffery R, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369-1376.
9. Forsblom CM, Groop PH, Ekstrand A, Groop LC (1992) Predictive value of microalbuminuria in patients with insulindependent diabetes of long duration. Br Med J 305:1051-1053.
10. Freedman BI, Yu H, Spray BJ, et al. (1997) Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 51:819-825.
11. Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin- 6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847-850.
12. Iida Y, Miyata T, Inagi R, et al. (1994) b2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis- associated amyloidosis. Biochem Biophys Res Commun 30:1235-1241.
13. Kitamura A, Hasegawa G, Obayashi H, et al. (2002) Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 19:1000-1005.
14. Kristiansen OP, Nolse RL, Larsen L, et al. (2003) Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early onset type 1 diabetes in females. Hum Mol Genet 12:1101-1110.
15. Ksiazek P, Bednarek-Skublewsk A, Buraczynska M (2004) The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 10:BR47-BR51.
16. Mattock MB, Morrish NJ, Viberti G, et al. (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:736-741.
17. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360.
18. Mohamed-Ali V, Pinkney JH, Coppack SW (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145-1158.
19. Morohoshi M, Fujisawa K, Uchimura I, Numano F (1995) The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann N Y Acad Sci 748:562-570.
20. Nakajima T, Ota N, Yoshida H, et al. (1999) Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1:115-119.
21. Ruef C, Budde K, Lacy J, et al. (1990) Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int 38:249-257.
22. Sekizuka K, Tomino Y, Sei C, et al. (1994) Detection of serum IL-6 in patients with diabetic nephropathy. Nephron 68:284-285.
23. Shpichinetsky V, Raz I, Friedlander Y, et al. (2000) The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type 2 diabetic patients. J Nutr 130:2493-2497.
24. Sun J, Xu Y, Zhu Y, Lu H (2004) Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64:185-190.
25. Suzuki D, Miyazaki M, Naka R, et al. (1995) In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44:1233-1238.
26. Tarnow L, Pociot F, Hansen PM, et al. (1997) Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 46:1075-1076.
27. Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144.
28. Vozarova B, Fernandez-Real JM, Knowler WC, et al. (2003) The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 112:409-413.